Biomarin pharmaceutical market cap

WebApr 6, 2024 · About the company. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and … WebApr 13, 2024 · The business’s fifty day moving average price is $99.47 and its 200 day moving average price is $98.40. The firm has a market capitalization of $18.27 billion, a …

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by …

WebView the latest BioMarin Pharmaceutical Inc. (BMRN) stock price, news, historical charts, analyst ratings and financial information from WSJ. Web2 days ago · -- Jean Jacques Bienaime, Director, Chief Executive Officer, on April 10, 2024, sold 10,000 shares in Biomarin Pharmaceutical for $995,600. Following the Form 4 … d and d wizard https://bloomspa.net

BioMarin Pharmaceutical Inc. (BMRN) - Yahoo Finance

WebApr 10, 2024 · Biomarin Pharmaceutical Inc.'s market capitalization is $18.49 B by 186.53 M shares outstanding. Is Biomarin Pharmaceutical stock a Buy, Sell or Hold? … WebApr 10, 2024 · BMRN Complete BioMarin Pharmaceutical Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. … WebBioMarin Pharmaceutical Symbol: BMRNRank: #820Price: $111.81(-0.9128%) Market Cap: $20.7B($-189.6M)Industry: BiotechnologySector: HealthcareCountry: United StatesInsiders: 0.552%Institutions: 101.394% BioMarin Pharmaceutical Inc. Technicals 52 Week High: $114.8 52 Week Low: $70.73 50 Day MA: $99.43 200 Day MA: $88.59 d and d wolf stats

Is Now A Good Time To Buy BioMarin Stock? The Motley Fool

Category:BioMarin Pharmaceutical (BMRN) - Market capitalization

Tags:Biomarin pharmaceutical market cap

Biomarin pharmaceutical market cap

BMRN Stock Forecast, Price & News (BioMarin Pharmaceutical) - Market…

WebApr 3, 2024 · BioMarin Pharmaceutical Inc. has a 12 month low of $70.73 and a 12 month high of $117.77. The company has a debt-to-equity ratio of 0.24, a current ratio of 4.67 and a quick ratio of 3.15. The company has a market cap of $18.07 billion, a price-to-earnings ratio of 131.41 and a beta of 0.39. WebApr 11, 2024 · With Biomarin Pharmaceutical stock trading at $94.30 per share, the total value of Biomarin Pharmaceutical stock (market capitalization) is $17.59B. Biomarin …

Biomarin pharmaceutical market cap

Did you know?

WebApr 12, 2024 · The stock has a market capitalization of $18.25 billion, a PE ratio of 132.22 and a beta of 0.38. BioMarin Pharmaceutical ( NASDAQ:BMRN – Get Rating) last announced its quarterly earnings... WebApr 10, 2024 · See the latest Biomarin Pharmaceutical Inc stock price (NASDAQ:BMRN), related news, valuation, dividends and more to help you make your investing decisions. …

WebCurrent and historical revenue charts for BioMarin Pharmaceutical. As of April 2024 BioMarin Pharmaceutical's TTM revenue is of $2.09 B. companies: 7,323 total market … WebApr 11, 2024 · The firm has a market capitalization of $18.29 billion, a P/E ratio of 132.50 and a beta of 0.38. BioMarin Pharmaceutical Inc. has a fifty-two week low of $70.73 and a fifty-two week high...

WebApr 13, 2024 · BioMarin Pharmaceutical Stock Performance NASDAQ:BMRN opened at $97.96 on Thursday. The firm has a market capitalization of $18.27 billion, a PE ratio of 132.38 and a beta of 0.38. The... WebApr 13, 2024 · The firm has a market capitalization of $18.27 billion, a PE ratio of 132.38 and a beta of 0.38. BioMarin Pharmaceutical Inc. has a 12 month low of $70.73 and a 12 month high of $117.77. The company has a debt-to-equity ratio of 0.24, a current ratio of 4.67 and a quick ratio of 3.15.

WebDec 30, 2024 · Pharma giant Pfizer recently announced that it will acquire Arena Pharmaceuticals for $100 per share or a total equity value of approximately $6.7 billion to further expand its portfolio. Per...

WebBioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research … d and d wizard 5eWebApr 10, 2024 · BioMarin Pharmaceutical's mailing address is 770 Lindaro Street, San Rafael CA, 94901. The official website for the company is www.bmrn.com. The biotechnology company can be reached via phone … d and d wizard schoolsWebFeb 9, 2024 · BioMarin Pharmaceutical Inc. Common Stock (BMRN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. ... Market … d and d wizard school of illusionWebApr 13, 2024 · The company has a market cap of $18.27 billion, a price-to-earnings ratio of 132.38 and a beta of 0.38. BioMarin Pharmaceutical Inc. has a twelve month low of $70.73 and a twelve month high... birmingham black barons 23Web2 days ago · Technical analysis trends BIOMARIN PHARMACEUTICAL INC. Technical analysis Income Statement Evolution More Financials Consensus Consensus EPS Revisions More Estimates Revisions Managers and Directors More about the company Sector and Competitors More Results birmingham blackburn highlightsWebApr 13, 2024 · The company has a market cap of $18.27 billion, a price-to-earnings ratio of 132.38 and a beta of 0.38. BioMarin Pharmaceutical Inc. has a twelve month low of … d and d wisdom vs intelligenceWebAccording to BioMarin Pharmaceutical 's latest financial reports the company's current revenue (TTM) is $2.09 B . In 2024 the company made a revenue of $1.84 B a decrease over the years 2024 revenue that were of $1.86 B .The revenue is the total amount of income that a company generates by the sale of goods or services. birmingham black business show